We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
+16.4%
1 Year Est. Return
+26.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$452K
AUM Growth
+$39.7K
Cap. Flow
-$28.6K
Cap. Flow %
-6.34%
Top 10 Hldgs %
100%
Holding
1
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CYCN icon
Cyclerion Therapeutics
CYCN
+$28.6K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYCN icon
1
Cyclerion Therapeutics
CYCN
$18.8M
$452K 100%
155,187
-9,590
-6% -$28.6K

Similar funds

Tyndall Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Tyndall Capital Partners held 1 position worth $452K, up 9.6% from $412K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners withdrew a net $28.6K in Q2 2025, reducing 1 holding. Its largest reduction was Cyclerion Therapeutics, cutting an estimated $28.6K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Tyndall Capital Partners's biggest Q2 2025 reduction was Cyclerion Therapeutics, cutting an estimated $28.6K.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $452K portfolio in Q2 2025.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q2 2025.
  • Tyndall Capital Partners's portfolio value rose 9.6% quarter-over-quarter to $452K.

Based on Tyndall Capital Partners's 13F filing for Q2 2025, filed 14 Aug 2025.